scholarly article | Q13442814 |
P356 | DOI | 10.1016/0035-9203(95)90101-9 |
P698 | PubMed publication ID | 8560535 |
P50 | author | Marco Albonico | Q56420299 |
P2093 | author name string | A Hall | |
P G Smith | |||
E Ercole | |||
L Savioli | |||
K S Alawi | |||
H M Chwaya | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | mebendazole | Q422194 |
P304 | page(s) | 538-541 | |
P577 | publication date | 1995-09-01 | |
P1433 | published in | Transactions of the Royal Society of Tropical Medicine and Hygiene | Q15766916 |
P1476 | title | Rate of reinfection with intestinal nematodes after treatment of children with mebendazole or albendazole in a highly endemic area | |
P478 | volume | 89 |
Q24810845 | "Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poor |
Q47846060 | A broad spectrum Kunitz type serine protease inhibitor secreted by the hookworm Ancylostoma ceylanicum. |
Q43585886 | A comparative study of different albendazole and mebendazole regimens for the treatment of intestinal infections in school children of Usigu Division, western Kenya. |
Q39360112 | Advances in vaccines against neglected tropical diseases: enhancing physical stability of a recombinant hookworm vaccine through biophysical and formulation studies |
Q30062048 | Advancing a vaccine to prevent hookworm disease and anemia |
Q37326963 | An enzymatically inactivated hemoglobinase from Necator americanus induces neutralizing antibodies against multiple hookworm species and protects dogs against heterologous hookworm infection |
Q30637848 | Ancylostoma secreted protein 1 (ASP-1) homologues in human hookworms |
Q91913919 | Anthelmintic drugs for treating ascariasis |
Q41454208 | Anthelmintics. A comparative review of their clinical pharmacology |
Q57922409 | Are schoolchildren less infected if they have good knowledge about parasitic worms? A case study from rural Côte d'Ivoire |
Q48041019 | Cloning and molecular characterization of cDNAs encoding three Ancylostoma ceylanicum secreted proteins. |
Q45830138 | Cluster-randomised trial of the impact of school-based deworming and iron supplementation on the cognitive abilities of schoolchildren in Sri Lanka's plantation sector. |
Q39013774 | Comparative immunology of human and animal models of hookworm infection |
Q33537291 | Control strategies for human intestinal nematode infections |
Q33627639 | Crystallization and preliminary X-ray analysis of Na-SAA-2 from the human hookworm parasite Necator americanus |
Q56420806 | Cutaneous and subcutaneous granulomata formation in mice immunized and challenged with third-stage infective hookworm (Ancylostoma caninum) larvae |
Q37800361 | Developing vaccines to combat hookworm infection and intestinal schistosomiasis |
Q45282296 | Earth-eating and reinfection with intestinal helminths among pregnant and lactating women in western Kenya |
Q39244367 | Effect of combining the larval antigens Ancylostoma secreted protein 2 (ASP-2) and metalloprotease 1 (MTP-1) in protecting hamsters against hookworm infection and disease caused by Ancylostoma ceylanicum |
Q28473967 | Effect of heterogeneous mixing and vaccination on the dynamics of anthelmintic resistance: a nested model |
Q27329637 | Efficacy and reinfection with soil-transmitted helminths 18-weeks post-treatment with albendazole-ivermectin, albendazole-mebendazole, albendazole-oxantel pamoate and mebendazole |
Q42254223 | Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis |
Q37064200 | Emerging and reemerging helminthiases and the public health of China |
Q24601973 | Epidemiology and control of human gastrointestinal parasites in children |
Q33784985 | Experimental approaches to the development of a recombinant hookworm vaccine. |
Q34438394 | Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials |
Q54216084 | Extracellular vesicles induce protective immunity against Trichuris muris. |
Q50904249 | Failure of pyrantel in treatment of human hookworm infections (Ancylostoma duodenale) in the Kimberley region of north west Australia. |
Q39057966 | Genetic structure of populations of the human hookworm, Necator americanus, in China |
Q34106772 | Geographical variation in Ascaris lumbricoides fecundity and its implications for helminth control |
Q39879927 | Geohelminth infection and re-infection after chemotherapy among slum-dwelling children in Durban, South Africa |
Q37772263 | Health metrics for helminthic infections |
Q57964233 | Hookworm infection |
Q36635886 | Hookworm vaccines: past, present, and future |
Q21090197 | Hookworm: "the great infection of mankind". |
Q33788299 | Host cytokine production, lymphoproliferation, and antibody responses during the course of Ancylostoma ceylanicum infection in the Golden Syrian hamster |
Q39078215 | Human anthelminthic vaccines: Rationale and challenges |
Q24652391 | Human hookworm infection in the 21st century |
Q56889464 | Impact of a national deworming campaign on the prevalence of soil-transmitted helminthiasis in Uganda (2004-2016): Implications for national control programs |
Q34999807 | Impact of health education on soil-transmitted helminth infections in schoolchildren of the Peruvian Amazon: a cluster-randomized controlled trial. |
Q28473703 | Impact of long-term treatment with ivermectin on the prevalence and intensity of soil-transmitted helminth infections |
Q36492729 | Intervention for the control of soil-transmitted helminthiasis in the community. |
Q39013387 | Lipopeptide Nanoparticles: Development of Vaccines against Hookworm Parasite |
Q81587196 | Mitochondrial DNA variation of the dog hookworm Ancylostoma caninum in Brazilian populations |
Q38895404 | Modeling the economic and epidemiologic impact of hookworm vaccine and mass drug administration (MDA) in Brazil, a high transmission setting |
Q33769088 | Molecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus |
Q51790901 | Mucosal antibody responses in experimental hookworm infection. |
Q35887080 | New tools for NTD vaccines: A case study of quality control assays for product development of the human hookworm vaccine Na-APR-1M74 |
Q38098308 | New vaccines for neglected parasitic diseases and dengue |
Q34855014 | Oral transfer of adult Ancylostoma ceylanicum hookworms into permissive and nonpermissive host species |
Q34442381 | Peptide-based subunit vaccine against hookworm infection |
Q34240815 | Pharmacotherapy of ascariasis |
Q36402476 | Profiling Nonrecipients of Mass Drug Administration for Schistosomiasis and Hookworm Infections: A Comprehensive Analysis of Praziquantel and Albendazole Coverage in Community-Directed Treatment in Uganda |
Q34246851 | Progress in the development of a recombinant vaccine for human hookworm disease: the Human Hookworm Vaccine Initiative |
Q37117571 | Purification and molecular cloning of and immunization with Ancylostoma ceylanicum excretory-secretory protein 2, an immunoreactive protein produced by adult hookworms |
Q34768601 | Randomized, placebo-controlled, double-blind trial of the Na-ASP-2 hookworm vaccine in unexposed adults |
Q37107970 | Rapid re-infection with soil-transmitted helminths after triple-dose albendazole treatment of school-aged children in Yunnan, People's Republic of China |
Q37307676 | Rates and intensity of re-infection with human helminths after treatment and the influence of individual, household, and environmental factors in a Brazilian community |
Q35690054 | Reduction of worm fecundity and canine host blood loss mediates protection against hookworm infection elicited by vaccination with recombinant Ac-16. |
Q35120071 | School-based health education targeting intestinal worms-further support for integrated control |
Q21144506 | Soil-transmitted helminth infections among plantation sector schoolchildren in Sri Lanka: prevalence after ten years of preventive chemotherapy |
Q21562255 | Soil-transmitted helminth reinfection after drug treatment: a systematic review and meta-analysis |
Q34147961 | Structure of glutathione S-transferase 1 from the major human hookworm parasite Necator americanus (Na-GST-1) in complex with glutathione. |
Q27679330 | Structure of monomericNa-GST-3, a glutathioneS-transferase from the major human hookworm parasiteNecator americanus |
Q51339334 | Study design and baseline results of an open-label cluster randomized community-intervention trial to assess the effectiveness of a modified mass deworming program in reducing hookworm infection in a tribal population in southern India. |
Q44959526 | Sustainability of soil-transmitted helminth control following a single-dose co-administration of albendazole and diethylcarbamazine |
Q46658643 | The Effect of Deworming Using Triple-Dose Albendazole on Nutritional Status of Children in Perobatang Village, Southwest Sumba, Indonesia. |
Q98465722 | The Heterogeneity, Origins, and Impact of Migratory iILC2 Cells in Anti-helminth Immunity |
Q37706375 | The Human Hookworm Vaccine |
Q33452532 | The hookworm tissue inhibitor of metalloproteases (Ac-TMP-1) modifies dendritic cell function and induces generation of CD4 and CD8 suppressor T cells |
Q35126837 | The role of health education and sanitation in the control of helminth infections |
Q34004434 | Two quantitative trait loci influence whipworm (Trichuris trichiura) infection in a Nepalese population |
Q38395403 | Update on prevention and treatment of intestinal helminth infections |
Q21563438 | Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogs |
Q36726742 | Vaccines against blood-feeding nematodes of humans and livestock |
Q30425005 | Vaccines to combat the neglected tropical diseases |
Q27646442 | X-ray structures of Na-GST-1 and Na-GST-2 two glutathione s-transferase from the human hookworm Necator americanus |
Search more.